Loss of vitality with age stands to become a thing of the past.

This fall the Utah based, global direct selling Company, Nu Skin Enterprises, (NYSE: NUS) will introduce a new approach to anti aging at the level of genetic expression of aging with the ultimate goal of increasing a healthy life span, according to a PR Newswire press release, dated 13 July 2010.

“We are supported by a partnership with some of the best minds in anti aging science”, said Dr. Joseph Chang, Ph.D., Nu Skin chief scientific officer and executive vice president of product development, who – together with Nu Skin´s exclusive partner, LifeGen Technologies – presented research on the identification of genetic biomarkers of aging, and how gene expression can be modulated by dietary interventions.

Speaking at the first International Congress on Controversies in Longevity, Health and Aging (CoLONGY) in Barcelona, Spain, Dr. Chang said: “Identifying functional Youth Gene Clusters and understanding how ingredients can target and reset those genes to a more youthful profile helps us develop next-generation skin care and nutritunal products”.

Details of the joint research was presented by Dr. Jamie Barger, Ph.D., director of laboratory operations for LifeGen. The research has identified robust, tissue-specific panels of transcriptional biomarkers that are relevant to aging, the press release states.”Studies using whole-genome profiles of gene expression have identified thousands of genes that change activity patterns with age. Nu Skin is currently using these biomarkers in a pre-clinical study of dietary compounds to determine their ability to impact aging at the genetic expression level.”

CoLONGY is an exclusive forum for international experts in Health, science and aging to share and compare recent findings and research, where scientists, doctors and researchers can come together to discuss and understand the processes of aging in relation to health.

Nu Skin´s partner, LifeGen Technologies, holds a patent for the use of “gene expression profiling” as a method to measure the progression of the aging process at the molecular level in individual organs, which is a key component of the partnership.Chang, Ph.D. explains in this YouTube interview with CBS News what the new technology is all about. Click to watch